Nirvana Life Sciences Inc.
NIRVF
$0.083
$0.0830.00%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -397.40K | -337.90K | -417.20K | -646.90K | -910.50K |
| Total Depreciation and Amortization | 4.50K | 13.50K | 13.50K | 13.50K | 25.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 136.00K | 46.90K | 60.40K | 228.20K | 612.80K |
| Change in Net Operating Assets | 220.80K | 245.10K | 280.00K | 264.00K | 84.10K |
| Cash from Operations | -36.00K | -32.40K | -63.30K | -141.30K | -187.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 4.60K | 49.50K | 25.50K | 28.20K | -9.50K |
| Total Debt Repaid | -35.80K | 50.00K | 50.00K | 0.00 | -50.00K |
| Issuance of Common Stock | -- | 0.00 | 25.00K | 210.10K | 320.00K |
| Repurchase of Common Stock | -59.10K | -59.10K | -59.10K | -59.10K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 9.10K | 9.10K | 9.10K | 0.00 | -9.10K |
| Cash from Financing | -55.80K | 36.30K | 37.10K | 133.80K | 187.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 84.30K | -11.30K | -2.20K | -- | -- |
| Net Change in Cash | -7.50K | -7.40K | -28.30K | -7.40K | -400.00 |